INTELLIA THERAPEUTICS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $1.52M, a 22.88% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $1.24M, a 25.88% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $1.67M, a 18.63% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $2.05M, a 92.04% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $2.59M, a 13.30% decline from fiscal 2024.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $2.99M, a 24.00% decline from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $3.93M, a 48.32% increase from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $2.65M, a 30.88% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $1.52M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $2.59M 10-K · filed 2026-02-26 | |
| 2025-06-30 | $1.24M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $2.99M 10-K · filed 2026-02-26 | |
| 2024-06-30 | $1.67M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $3.93M 10-K · filed 2026-02-26 | |
| 2023-06-30 | $2.05M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $2.65M 10-K · filed 2025-02-27 | |
| 2022-06-30 | $1.07M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $2.02M 10-K · filed 2024-02-22 | |
| 2021-06-30 | $970.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $1.56M 10-K · filed 2023-02-23 | |
| 2020-06-30 | $685.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $1.09M 10-K · filed 2022-02-24 | |
| 2019-06-30 | $534.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $1.02M 10-K · filed 2021-02-26 | |
| 2018-06-30 | $598.00K 10-Q · filed 2019-10-31 | |
| 2017-12-31 | $825.00K 10-K · filed 2020-02-27 | |
| 2016-12-31 | $259.00K 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |